Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2)

被引:240
作者
Kotze, AF [1 ]
Luessen, HL
de Leeuw, BJ
de Boer, BG
Verhoef, JC
Junginger, HE
机构
[1] Potchefstroom Univ Christian Higher Educ, Dept Pharmaceut, ZA-2520 Potchefstroom, South Africa
[2] LTS Lohmann Therapie Syst GMBH, D-56605 Andernach, Germany
[3] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Dept Pharmaceut Technol, NL-2300 RA Leiden, Netherlands
[4] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Dept Pharmacol, NL-2300 RA Leiden, Netherlands
关键词
chitosan; N-trimethyl chitosan chloride; absorption enhancers; paracellular transport; transepithelial electrical resistance; confocal laser scanning microscopy;
D O I
10.1016/S0168-3659(97)00154-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A partially quaternized chitosan derivative, N-trimethyl chitosan chloride (TMC) (degree of quaternization 12.28%), was synthesized and the effects of this novel polymer on the permeability of intestinal epithelial cells, using Caco-2 cell monolayers, were investigated and compared with those of chitosan hydrochloride and chitosan glutamate. Transepithelial electrical resistance (TEER) measurements at pH 6.20 revealed that all these polymers (0.25-1.5% w/v) caused an immediate and pronounced lowering in TEER values in the order chitosan hydrochloride (84% reduction after 2 h incubation) > chitosan glutamate (60% reduction) > TMC (24% reduction) at 0.25% w/v concentrations. At higher concentrations (up to 2.5% w/v), TMC was able to decrease the TEER further. Similar results were obtained in transport studies, using the hydrophilic radioactive markers, [C-14]-mannitol (MW 182.2) and [C-14]-polyethylene glycol 4000 (PEG-4000, MW 4000). Large increases in the permeation of these markers were found. The transport of [C-14]-mannitol was increased 34-fold (chitosan hydrochloride), 25-fold (chitosan glutamate) and Ii-fold (TMC) at 0.25% w/v concentrations. Further increases in the permeation of both markers were found at higher concentrations of TMC. Due to its quaternary structure, TMC is better soluble than the other chitosan salts, and its higher solubility may compensate for its lesser effectivity at similar concentrations. It is also soluble at pH 7.40, where the chitosan salts are insoluble and therefore ineffective. No deleterious effects to the cells could be demonstrated with trypan blue exclusion studies and confocal laser scanning microscopy (CLSM). CLSM confirmed that these polymers increase the transport of large hydrophilic compounds (using the fluorescent markers FD-4, MW 4400 and FD-20, MW 19600) through opening of tight junctions to allow for paracellular transport. It is concluded from this study that the charge, charge density and the structural features of chitosans and chitosan derivatives are important factors determining their potential use as absorption enhancers. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:35 / 46
页数:12
相关论文
共 22 条
[1]   EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
ARTURSSON, P ;
LINDMARK, T ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1358-1361
[2]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .2. EFFECT OF EXTRACELLULAR CALCIUM-CONCENTRATION ON THE PARACELLULAR TRANSPORT OF DRUGS OF DIFFERENT LIPOPHILICITIES ACROSS MONOLAYERS OF INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
MAGNUSSON, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (07) :595-600
[3]   The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption .3. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro [J].
Borchard, G ;
Luessen, HL ;
deBoer, AG ;
Verhoef, JC ;
Lehr, CM ;
Junginger, HE .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :131-138
[4]   BISPHOSPHONATES INCREASE TIGHT JUNCTION PERMEABILITY IN THE HUMAN INTESTINAL EPITHELIAL (CACO-2) MODEL [J].
BOULENC, X ;
ROQUES, C ;
JOYEUX, H ;
BERGER, Y ;
FABRE, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 123 (01) :13-24
[5]   NEW METHOD FOR THE QUATERNIZATION OF CHITOSAN [J].
DOMARD, A ;
RINAUDO, M ;
TERRASSIN, C .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1986, 8 (02) :105-107
[6]  
FIX J A, 1987, Journal of Controlled Release, V6, P151, DOI 10.1016/0168-3659(87)90072-1
[7]  
GUMBINER B, 1987, AM J PHYSIOL, V253, P749
[8]   MECHANISMS OF ABSORPTION ENHANCEMENT AND TIGHT JUNCTION REGULATION [J].
HOCHMAN, J ;
ARTURSSON, P .
JOURNAL OF CONTROLLED RELEASE, 1994, 29 (03) :253-267
[9]  
HURNI MA, 1993, J PHARMACOL EXP THER, V267, P942
[10]   CHITOSAN AS A NOVEL NASAL DELIVERY SYSTEM FOR PEPTIDE DRUGS [J].
ILLUM, L ;
FARRAJ, NF ;
DAVIS, SS .
PHARMACEUTICAL RESEARCH, 1994, 11 (08) :1186-1189